Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response

被引:648
|
作者
Astuti, Indwiani [1 ]
Ysrafil [1 ]
机构
[1] Univ Gadjah Mada, Dept Pharmacol & Therapy, Fac Med Publ Hlth & Nurses, Yogyakarta 55281, Indonesia
关键词
COVID-19; SARS-CoV-2; Pandemic; ACE2; Wuhan; RECEPTOR-BINDING DOMAIN; SPIKE PROTEIN; IMMUNE-RESPONSES; SARS-COV; NEUTRALIZING ANTIBODIES; COVID-19; VACCINE; INFECTION; ENZYMES; TARGET;
D O I
10.1016/j.dsx.2020.04.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim: As a result of its rapid spread in various countries around the world, on March 11, 2020, WHO issued an announcement of the change in coronavirus disease 2019 status from epidemic to pandemic disease. The virus that causes this disease is indicated originating from animals traded in a live animal market in Wuhan, China. Severe Acute Respiratory Syndrome Coronavirus 2 can attack lung cells because there are many conserved receptor entries, namely Angiotensin Converting Enzyme-2. The presence of this virus in host cells will initiate various protective responses leading to pneumonia and Acute Respiratory Distress Syndrome. This review aimed to provide an overview related to this virus and examine the body's responses and possible therapies. Method: We searched PubMed databases for Severe Acute Respiratory Syndrome Coronavirus-2, Middle East respiratory syndrome-related coronavirus and Severe Acute Respiratory Syndrome Coronavirus. Full texts were retrieved, analyzed and developed into an easy-to-understand review. Results: We provide a complete review related to structure, origin, and how the body responds to this virus infection and explain the possibility of an immune system over-reaction or cytokine storm. We also include an explanation of how this virus creates modes of avoidance to evade immune system attacks. We further explain the therapeutic approaches that can be taken in the treatment and prevention of this viral infection. Conclusion: In summary, based on the structural and immune-evasion system of coronavirus, we suggest several approaches to treat the disease. (C) 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:407 / 412
页数:6
相关论文
共 50 条
  • [1] Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine
    Mirzaei, Rasoul
    Mohammadzadeh, Rokhsareh
    Mahdavi, Farzad
    Badrzadeh, Fariba
    Kazemi, Sheida
    Ebrahimi, Mehdi
    Soltani, Fatemeh
    Kazemi, Sima
    Jeda, Ali Salimi
    Darvishmotevalli, Mohammad
    Yousefimashouf, Rasoul
    Keyvani, Hossein
    Karampoor, Sajad
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 88
  • [2] Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection
    Synowiec, Aleksandra
    Szczepanski, Artur
    Barreto-Duran, Emilia
    Lie, Laurensius Kevin
    Pyrc, Krzysztof
    CLINICAL MICROBIOLOGY REVIEWS, 2021, 34 (02) : 1 - 32
  • [4] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review
    Feng, Wei
    Zong, Wei
    Wang, Feng
    Ju, Shaoqing
    MOLECULAR CANCER, 2020, 19 (01)
  • [5] Importance of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus Viral Components: A Comprehensive Review
    Abd Alfatlawi, Monyer Abdulameir
    Al-Obaidy, Osama Hadi
    Mayea, Khetam Qaid
    JOURNAL OF PIONEERING MEDICAL SCIENCES, 2025, 14 (02): : 82 - 95
  • [6] Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
    O'Leary, Valerie Brid
    Ovsepian, Saak Victor
    TRENDS IN GENETICS, 2020, 36 (11) : 892 - 893
  • [7] Overview of Hydroxychloroquine and Remdesivir on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
    Kabi, Arup K.
    Pal, Maynak
    Gujjarappa, Raghuram
    Malakar, Chandi C.
    Roy, Mithun
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2023, 60 (02) : 165 - 182
  • [8] Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines
    Pecetta, Simone
    Kratochvil, Sven
    Kato, Yu
    Vadivelu, Kumaran
    Rappuoli, Rino
    PHARMACOLOGICAL REVIEWS, 2022, 74 (01) : 313 - 339
  • [9] A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV)
    Noor, Rashed
    ARCHIVES OF MICROBIOLOGY, 2021, 203 (05) : 1943 - 1951
  • [10] Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a newly emerged pathogen: an overview
    Rathore, Jitendra Singh
    Ghosh, Chaitali
    PATHOGENS AND DISEASE, 2020, 78 (06):